Company news
Aroa Biosurgery Ltd (ASX:ARX) news
Every Aroa Biosurgery Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
September 6, 2026
FY26 Full Year Results Presentation
May 25, 2026
ARX FY26 Preliminary Results
April 29, 2026
Symphony Randomised Control Trial Complete
March 29, 2026
AROA Business Update Presentation
February 2, 2026
AROA Business Update
February 2, 2026
Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
January 22, 2026
Aroa Biosurgery H1 FY26 Results
November 24, 2025
Appendix 4D and Half Year Report
November 24, 2025
September 2025 Quarterly Report and Appendix 4C
October 15, 2025
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
August 28, 2025
June 2025 Quarterly Report and Appendix 4C
July 28, 2025
FY25 Appendix 4E and Full Year Results
May 28, 2025
FY25 Full Year Results Presentation
May 28, 2025
AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
May 1, 2025
March 2025 Quarterly Report and Appendix 4C
April 28, 2025
December 2024 Quarterly Report and Appendix 4C
January 28, 2025
Aroa Half Year Results Presentation
November 25, 2024
Aroa Biosurgery Half Yearly Results H1 FY25
November 25, 2024
September 2024 Quarterly Report and Appendix 4C
October 21, 2024
June 2024 Quarterly Report and Appendix 4C
July 23, 2024
FY24 Full Year Results Presentation
May 20, 2024
FY24 Appendix 4E and Full Year Results
May 20, 2024
March 2024 Quarterly Report and Appendix 4C
April 29, 2024
December 2023 Quarterly Report and Appendix 4C
January 29, 2024
Aroa Biosurgery Half Yearly Results H1 FY24
November 27, 2023
September 2023 Quarterly Report and Appendix 4C
October 30, 2023
June 2023 Quarterly Report and Appendix 4C
July 30, 2023
FY23 Full Year Results Presentation
May 30, 2023
FY23 Appendix 4E and Full Year Results
May 30, 2023
March 2023 Quarterly Report and Appendix 4C
April 26, 2023
AROA secures first FDA clearance for ENIVO system
April 11, 2023
December 2022 Quarterly Report and Appendix 4C
January 30, 2023
Aroa Biosurgery Half Yearly Report H1 FY23
November 30, 2022
Aroa Biosurgery Announces Half Year Results
November 29, 2022
Aroa Biosurgery Half Yearly Results H1 FY23
November 28, 2022
September 2022 Quarterly Report and Appendix 4C
October 24, 2022
June Quarterly Report and Appendix 4C
July 25, 2022
FY22 Full Year Results Presentation
May 23, 2022
FY22 Appendix 4E and Full Year Results
May 23, 2022
March Quarterly Report and Appendix 4C
April 25, 2022
December Quarterly Report and Appendix 4C
January 27, 2022
Aroa Biosurgery Half Yearly Report H1 FY21
November 24, 2021
September Quarterly Report and Appendix 4C
October 26, 2021
Aroa delivers strong half, Myriad GPO win
October 5, 2021
Investor Presentation
July 28, 2021
Aroa Completes $47m Placement and Launches $5m SPP
July 28, 2021
Trading Halt
July 26, 2021
FY21 Full Year Results Presentation
May 24, 2021
Preliminary Final Report
May 24, 2021